Results 11 to 20 of about 10,635 (224)

A Clinical Study on the Use of Methotrexate in Rheumatoid Arthritis Based on CDAI Score [PDF]

Journal of Drug Delivery and Therapeutics, 2022
Methotrexate (MTX) has been used in the treatment of rheumatoid arthritis for more than 2 decades. It has proven its efficacy in the treatment of rheumatoid arthritis in numerous randomized controlled trials. Compared with other second-line drugs, a higher percentage of patients can continue therapy with MTX over a prolonged period.
K Bhavy, T Vivek, P Devanshi, P Radhika, K Anjali   +4 more
openaire   +2 more sources

Team coaching through CDAI and the GLP

, 2019
This chapter illustrates how Collaborative Developmental Action Inquiry (CDAI) theory, method, and practice can be used to simultaneously assess and transform leaders, teams, and organizations, through a non-formulaic coaching and consulting process that becomes increasingly self-transforming and collaborative as it evolves.
Cara Miller, Bill Torbert, Nancy Wallis, Karen C. Yeyinmen   +3 more
openaire   +2 more sources

Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease

BMC Gastroenterology, 2023
Abstract Background Mucosal healing has become the primary treatment target for patients with Crohn’s disease (CD). We aimed to develop a noninvasive and convenient tool to evaluate the endoscopic activity in patients with ileocolic CD.
Xiaolin Hu, Jiajia Li, Yunyun Sun, Dacheng Wu, Tiantian Zhao, Maofeng Ma, Jie Chen, Mei Wang, Sicong Hou   +8 more
openaire   +4 more sources

Bowel perforation in Crohn's Disease: correlation between CDAI and Clavien-Dindo scores [PDF]

Giornale di Chirurgia - Journal of Surgery, 2017
Many studies have elaborated different kind of activity indices for Crohn's Disesase (CD) with the endpoint of univocally measure and evaluate the gravity of its lesions and symptoms.Purpose of this work is to study and define the correlation that runs between the preoperative score obtained at the Crohn's Disease Activity Index, the occurrence of ...
Fontana T, Falco N, TORCHIA, Marina, Tutino R, Gulotta G.   +4 more
openaire   +4 more sources

Disrupted Functional Network Organization in Crohn's Disease: Interoceptive Alterations Linked to Anxiety. [PDF]

CNS Neurosci Ther
Crohn's disease shows widespread disruption and reorganization of functional brain networks, with altered activity in core interoceptive regions involved in sensory and emotional processing. Emotional disturbances modulate brain network dynamics, providing insight into neural mechanisms linking disease activity and affective symptoms.
Xu S, Bao C, Zhu X, Wang Q, Zhang B, Wu L, Li H, Yu X, Hao Z, Chen Z, Wang H, Wu H.   +11 more
europepmc   +2 more sources

THE ASSESSMENT OF MRE FINDINGS ACCORDING TO CDAI SCORE IN PATIENTS WITH CROHN’S DISEASE [PDF]

Gastroenterology, 2022
Abstract INTRODUCTION Crohn’s disease (CD) is a chronic inflammatory bowel disease of the gastrointestinal tract. One of the diagnostic steps is to perform a magnetic resonance enterography (MRE). The purpose of the study was to compare MRE findings with clinical index of the disease activity - CDAI ...
Monika Zbroja, Maryla Kuczynska, Weronika Cyranka, Malgorzata Nowakowska, Magdalena Grzegorczyk, Karolina Siejka, Monika Piekarska   +6 more
openaire   +1 more source

Joint and Independent Associations of Dietary Antioxidant Intakes With Advanced Stages in Older Patients With Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

Kaohsiung J Med Sci
ABSTRACT This study explored the association between the composite dietary antioxidant index (CDAI) and cardiovascular‐kidney‐metabolic (CKM) progression in an older population. Using data from NHANES 2001–2020, we analyzed 4974 adults aged ≥ 60 years with CKM syndrome. The CDAI was calculated from the intake of six dietary antioxidants.
Qiu FS, Qi JC, Lin MZ, Ke JH.
europepmc   +2 more sources

CDAI trajectories in patients with rheumatoid arthritis treated with abatacept in real-world. [PDF]

Adv Rheumatol
Abstract Background To describe the 12-month Clinical Disease Activity Index (CDAI) trajectory patterns and their determinants in patients with rheumatoid arthritis (RA) treated with subcutaneous abatacept.
Pope JE, Sampalis JS, Haraoui B, Rampakakis E, Keating D, Allum F, Trepanier MO, Bessette L.   +7 more
europepmc   +2 more sources

Comparison of total CDAI as computed using CDAI elements ascertained informatically vs manually.

, 2023
The y-axis corresponds to the CDAI calculated by database query of non-PRO3 elements. The x-axis corresponds to the CDAI calculated by manual abstraction.
Christel Chehoud (3170919), Benjamin D. Martini (14710246), Saquib Rahim (14710240), Yao-Wen Cheng (14710219), Vivek A. Rudrapatna (14710216), Uma Mahadevan (14710231), Olivia Roberson (14710228), Atul J. Butte (8032262), Jonathan Shih (14710225), Mark Curran (3450356), Christopher O’Brien (9726044), Benjamin Rubin (169516), Natalie Terry (8871698), Colin Feuille (14710222), Yongmei Shi (315077), Ngozi Erondu (14710237), Arman Mosenia (9334670), Nicholas Skomrock (14710234), Najat S. Khan (2222170), David Apfel (14710243)   +19 more
core   +1 more source

Rheumatoid Arthritis Effects on Kidney and Liver and their Correlations with CDAI

Journal of Techniques, 2022
Rheumatoid arthritis (RA) is a disease characterized by chronic autoimmune inflammation of body joints, causing movement disability, loss of functions, joint damage, and many complications. Persistent usage of anti-rheumatic drugs has several side effects, which may cause heart, kidney, or liver diseases.
Tamara Salman Mohammed, Raya Ezat Maroof, Ali Hussein Al-Hafidh   +2 more
openaire   +2 more sources